is anyone clear on LTP's relationship with SDS, my understanding is LTP have a licensing agreement with them and pay up to $3M to use Spontan, there have been a couple of variations that means now the total is around $4M.
does anyone see it a different way or do I have it wrong? Just curious whether there is any ongoing requirement for LTP to pay SDS if the drug becomes really successful.
is anyone clear on LTP's relationship with SDS, my understanding...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
-0.020(6.45%) |
Mkt cap ! $32.46M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 30.5¢ | 28.5¢ | $199.8K | 680.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 58285 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 3162 | 1 |
View Market Depth
| Last trade - 16.10pm 13/06/2025 (20 minute delay) ? |
| LTP (ASX) Chart |